Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 88983238 |
Registration Number | 6591373 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Attorney Name | Janet G Ricciuti |
Attorney Docket Number | 44422-2 |
Law Office Assigned | L90 |
Employee Name | THOMPSON, HEATHER |
2018-09-13 | Application Filed |
2019-02-03 | Date of First Use |
2019-05-14 | Published for Opposition |
2021-11-10 | Location: PUBLICATION AND ISSUE SECTION |
2021-11-10 | Status: Live/Pending |
2021-11-10 | Transaction Date |
2021-12-14 | Trademark Registered |
Owner: | ![]() |
Address | 515 COLOROW DRIVE SALT LAKE CITY DE 84108 |
Legal Entity Type | Limited Liability Company |
Legal Entity State | DE |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 5 |
U.S. Codes: | 005,006,018,044,046,051,052 |
International Codes: | 9 |
U.S. Codes: | 021,023,026,036,038 |
International Codes: | 10 |
U.S. Codes: | 026,039,044 |
Type Code | Type |
---|---|
GS0051 | Chemical and biochemical reagents for medical purposes; biological reagents, namely, biological preparations for the detection, analysis and quantification of microbial contaminants for medical diagnosis and for research purposes; chemical reagents and culture media for in-vitro medical diagnosis; Medical diagnostic reagents and assays that test for the presence of pathogens and infection; Medical diagnostic kits comprised of medical diagnostic reagents and assays that test for the presence of pathogens and infection; Medical diagnostic reagents and assays that test body fluids for microorganisms; Medical diagnostic kits comprised of medical diagnostic reagents and assays that test body fluids for microorganisms; Medical diagnostic reagents for the extraction, amplification, and purification of nucleic acids; Clinical medical reagents and assays for the extraction, amplification, and purification of nucleic acids |
GS0051 | Chemical and biochemical reagents for medical purposes; biological reagents, namely, biological preparations for the detection, analysis and quantification of microbial contaminants for medical diagnosis and for research purposes; chemical reagents and culture media for in-vitro medical diagnosis; Medical diagnostic reagents and assays that test for the presence of pathogens and infection; Medical diagnostic kits comprised of medical diagnostic reagents and assays that test for the presence of pathogens and infection; Medical diagnostic reagents and assays that test body fluids for microorganisms; Medical diagnostic kits comprised of medical diagnostic reagents and assays that test body fluids for microorganisms; Medical diagnostic reagents for the extraction, amplification, and purification of nucleic acids; Clinical medical reagents and assays for the extraction, amplification, and purification of nucleic acids |
Description | Date | Event Coding |
---|---|---|
NEW APPLICATION ENTERED IN TRAM | 2018-09-17 | 1 NWAP I:Incoming Correspondence |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-09-20 | 2 NWOS I:Incoming Correspondence |
ASSIGNED TO EXAMINER | 2018-12-26 | 3 DOCK D:Assigned to Examiner |
NON-FINAL ACTION WRITTEN | 2018-12-26 | 4 CNRT R:Renewal |
NON-FINAL ACTION E-MAILED | 2018-12-26 | 5 GNRT F:First Action |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2018-12-26 | 6 GNRN O:Outgoing Correspondence |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-03-12 | 7 TROA I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-03-12 | 8 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-03-13 | 9 TEME I:Incoming Correspondence |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2019-03-13 | 10 CNSA P: |
ASSIGNED TO LIE | 2019-03-31 | 11 ALIE A:Allowance for Publication |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2019-04-24 | 12 NONP E:E-Mail |
PUBLISHED FOR OPPOSITION | 2019-05-14 | 13 PUBO A:Allowance for Publication |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2019-05-14 | 14 NPUB E:E-Mail |
NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2019-07-09 | 15 NOAM E:E-Mail |
TEAS EXTENSION RECEIVED | 2019-12-11 | 16 EEXT I:Incoming Correspondence |
EXTENSION 1 FILED | 2019-12-11 | 17 EXT1 S: |
EXTENSION 1 GRANTED | 2019-12-11 | 18 EX1G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-12-13 | 19 EXRA E:E-Mail |
TEAS EXTENSION RECEIVED | 2020-06-12 | 20 EEXT I:Incoming Correspondence |
EXTENSION 2 FILED | 2020-06-12 | 21 EXT2 S: |
EXTENSION 2 GRANTED | 2020-06-12 | 22 EX2G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-06-16 | 23 EXRA E:E-Mail |
TEAS EXTENSION RECEIVED | 2020-12-07 | 24 EEXT I:Incoming Correspondence |
EXTENSION 3 FILED | 2020-12-07 | 25 EXT3 S: |
EXTENSION 3 GRANTED | 2020-12-07 | 26 EX3G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-12-09 | 27 EXRA E:E-Mail |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2021-07-08 | 28 REAP I:Incoming Correspondence |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2021-07-08 | 29 ARAA I:Incoming Correspondence |
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | 2021-07-08 | 30 EWAF I:Incoming Correspondence |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2021-07-08 | 31 TCCA I:Incoming Correspondence |
TEAS EXTENSION RECEIVED | 2021-07-08 | 32 EEXT I:Incoming Correspondence |
CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2021-07-16 | 33 AITU A:Allowance for Publication |
EXTENSION 4 FILED | 2021-07-08 | 34 EXT4 S: |
EXTENSION 4 GRANTED | 2021-07-16 | 35 EX4G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2021-07-17 | 36 EXRA E:E-Mail |
TEAS STATEMENT OF USE RECEIVED | 2021-09-07 | 37 EISU I:Incoming Correspondence |
ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST | 2021-10-27 | 38 INCD O:Outgoing Correspondence |
TEAS POST PUBLICATION AMENDMENT RECEIVED | 2021-11-01 | 39 EPPA I:Incoming Correspondence |
TEAS REQUEST TO DIVIDE RECEIVED | 2021-09-07 | 40 ERTD I:Incoming Correspondence |
DIVISIONAL REQUEST RECEIVED | 2021-09-07 | 41 DRRR I:Incoming Correspondence |
DIVISIONAL PROCESSING COMPLETE | 2021-11-10 | 42 DPCC D:Assigned to Examiner |
USE AMENDMENT FILED | 2021-09-07 | 43 IUAF S: |
STATEMENT OF USE PROCESSING COMPLETE | 2021-11-10 | 44 SUPC I:Incoming Correspondence |
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2021-11-10 | 45 CNPR P: |
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2021-11-11 | 46 SUNA E:E-Mail |
REGISTERED-PRINCIPAL REGISTER | 2021-12-14 | 47 R.PR A:Allowance for Publication |
TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2022-09-16 | 48 COAR I:Incoming Correspondence |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2022-09-16 | 49 REAP I:Incoming Correspondence |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2022-09-16 | 50 ARAA I:Incoming Correspondence |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2022-09-16 | 51 TCCA I:Incoming Correspondence |
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2022-09-16 | 52 CHAN I:Incoming Correspondence |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.